SCHEMBL27744873

SCHEMBL27744873

CCOC(=O)N(N)c1ncco1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.34
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
TP53 P04637 1/20 0.32
NUDT1 P36639 1/20 0.32
PIK3CA P42336 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.31
ALDH1A1 P00352 3/20 0.31
PKM P14618 1/20 0.31
HSD17B10 Q99714 3/20 0.31
FAAH O00519 2/20 0.31
KDM4E B2RXH2 1/20 0.31
CASP1 P29466 1/20 0.31
CES1 P23141 1/20 0.31
CYP1A2 P05177 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
HPGD P15428 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18964100 0.70 TRPM8 (0.37) TRPM8FAAHCES1KMT2ANPSR1
SCHEMBL28941701 0.69 PKM (0.47) TRPM8SMN1; SMN2L3MBTL1ALDH1A1PKM
SCHEMBL2422303 0.68 FAAH (0.43) NUDT1PIK3CAL3MBTL1ALDH1A1PKM
SCHEMBL11776990 0.68 CTDSP1 (0.48) L3MBTL1ALDH1A1HSD17B10KDM4ECASP1
SCHEMBL30753499 0.67 FAAH (0.42) ADORA2AADORA2BNUDT1PIK3CAL3MBTL1
SCHEMBL11264225 0.66 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1LMNAKMT2ANPSR1
Benzene SCHEMBL30353855 0.66 CES1 (0.43) ADORA2AADORA2BNUDT1L3MBTL1ALDH1A1
SCHEMBL3229623 0.66 CES1 (0.41) ALDH1A1PKMFAAHCES1CYP1A2
SCHEMBL30088772 0.66 ALDH1A1 (0.43) TRPM8L3MBTL1ALDH1A1FAAHCES1
SCHEMBL23484862 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101420950-B Treatment of duchenne muscular dystrophy SUMMIT CORP PLC 2012-04-18 CN disclosed
CN-101678107-A Pharmaceutical composition for treating Duchenne muscular dystrophy SUMMIT CORP PLC 2010-03-24 CN disclosed
CN-101420950-A Treatment of Duchenne muscular dystrophy SUMMIT CORP PLC (GB) 2009-04-29 CN disclosed